Clinical Trial Update: A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose study of PF-04620110 in adults with type 2 diabetes to assess safety, tolerability, and pharmacokinetics; the study is completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-04620110

Snippet

Sponsor: Pfizer | Conditions: Type 2 Diabetes Patients | Phase 1 | Status: COMPLETED | Results posted: 2012-11-06